Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in cont...

Full description

Saved in:
Bibliographic Details
Main Authors: V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, A. V. Syrov, A. V. Tarasov, A. I. Tarzimanova, O. N. Tkacheva, D. I. Trukhan
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2020-09-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
covid-19
comorbidity
permeability of mucosa
cardiovascular diseases
chronic obstructive pulmonary disease
diabetes
gastrointestinal diseases
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2630
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://cardiovascular.elpub.ru/jour/article/view/2630

Similar Items